Biotricity

Executive Summary

Biotricity is a digital health and medical device company focused on remote cardiac monitoring. Its FDA-cleared wearable rhythm monitors and cloud-based analytics platform enable real-time transmission and analysis of cardiac data, supporting faster clinical decisions for chronic condition management. Founded in 2012 and headquartered in Redwood City, California, the company operates in the growing remote monitoring market. With a subscription-based service model, Biotricity targets cardiologists and healthcare providers seeking to improve patient outcomes while reducing costs. The company has established a footprint in the US and continues to expand its product portfolio. Given the aging population and increasing prevalence of cardiac arrhythmias, Biotricity is well-positioned for growth. However, competition from larger players and dependence on reimbursement remain risks. Overall, the company’s technology and market focus present a compelling opportunity in the digital health space.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance for Next-Generation Patch Monitor with AI-enhanced arrhythmia detection70% success
• Q2 2026Partnership with a major health system for enterprise deployment of Biotricity's monitoring platform60% success
• Q3 2026Announcement of first profitable quarter or significant revenue growth milestone50% success